- Research article
- Open Access
Interactions between flagellar and type III secretion proteins in Chlamydia pneumoniae
© Stone et al; licensee BioMed Central Ltd. 2010
- Received: 27 July 2009
- Accepted: 22 January 2010
- Published: 22 January 2010
Flagellar secretion systems are utilized by a wide variety of bacteria to construct the flagellum, a conserved apparatus that allows for migration towards non-hostile, nutrient rich environments. Chlamydia pneumoniae is an obligate, intracellular pathogen whose genome contains at least three orthologs of flagellar proteins, namely FliI, FlhA and FliF, but the role of these proteins remains unknown.
Full length FliI, and fragments of FlhA, FliF, and FliI, were cloned and expressed as either GST or His tagged proteins in E. coli. The GST-tagged full length FliI protein was shown to possess ATPase activity, hydrolyzing ATP at a rate of 0.15 ± .02 μmol min-1 mg-1 in a time- and dose-dependant manner. Using bacterial-2-hybrid and GST pull-down assays, the N-terminal domain of FliI was shown to interact with the cytoplasmic domain of FlhA, but not with FliF, and the cytoplasmic domain of FlhA was shown to interact with the C-terminus of FliF. The absence of other flagellar orthologs led us to explore cross-reaction of flagellar proteins with type III secretion proteins, and we found that FliI interacted with CdsL and CopN, while FlhA interacted with CdsL and Cpn0322 (YscU ortholog CdsU).
The specific interaction of the four orthologous flagellar proteins in C. pneumoniae suggests that they interact in vivo and, taken together with their conservation across members of the chlamydiae sps., and their interaction with T3S components, suggests a role in bacterial replication and/or intracellular survival.
- ATPase Activity
- Inclusion Membrane
- Flagellar Apparatus
- Reticulate Body
- Flagellar Protein
Chlamydia pneumoniae is a gram negative, obligate intracellular pathogen that has been associated with community-acquired pneumonia , atherosclerosis , arthritis , and Alzheimer's disease . C. pneumoniae is characterized by a unique, biphasic life cycle beginning with an infectious, metabolically attenuated elementary body (EB). Chlamydial invasion is initiated by attachment of the EB to the host eukaryotic cell membrane and recruitment of actin to the site of attachment. This remodeling of the actin cytoskeleton is thought to be mediated by the type III secretion (T3S) effector protein, the translocated actin recruitment protein (TARP), which facilitates chlamydial entry into the host cell [5, 6]. Bacterial uptake involves modulation of the host MEK-ERK pathway and PI 3-kinase, possibly through the action of T3S effectors [7, 8]. Once internalized, the remainder of the chlamydial life cycle takes place within a parasitophorous membrane-bound vesicle known as an inclusion, where EBs differentiate into the non-infectious, metabolically active form, termed a reticulate body (RB). Within the inclusion, RBs acquire amino acids, nucleotides, lipids and cholesterol from the host cell, events possibly orchestrated via T3S across the inclusion membrane, while at the same time inhibiting apoptosis to ensure survival [9–11]. Golgi fragmentation appears to be a crucial step in intercepting host pathways to obtain these nutrients and compounds, as well as in the maturation of the chlamydiae sps. within the inclusion . The RB interacts with the inclusion membrane until such time as inclusion membrane RB docking sites are no longer available and an unknown signal triggers detachment of the RB from the inclusion membrane followed by asynchronous differentiation into EBs [13, 14]. The newly formed EBs then exit the cell by either cellular lysis or a packaged release mechanism termed extrusion .
C. pneumoniae encodes a full set of T3S genes scattered throughout the genome in several fragmented operons. The T3S injectisome has a high amount of paralogy to the flagellar secretion system in structure and in function. In the T3SS, CdsN is the ATPase that aids in shuttling effectors through the needle, and is paralogous to FliI . CdsL is orthologous to YscL and paralogous to FliH. In Yersinia, YscL is the ATPase tethering protein and functions to down-regulate enzymatic activity of YscN . CopN, orthologous to YopN, is believed to function as a regulator of the system which plugs the injectisome pore prior to activation of T3S and is a known effector protein . CdsU, orthologous to YscU, plays an important role is substrate specificity and substrate switching from structural components to effector proteins upon host cell contact . Recently, several reports have emerged characterizing protein interactions within the C. pneumoniae T3SS, describing novel protein complexes that form at the inner membrane. Johnson et al have shown that CdsD, a unique protein orthologous to YscD that contains two fork-head associated domains, interacts with the predicted C. pneumoniae ATPase tethering protein, CdsL, and CdsQ, a cytosolic component of the inner membrane that presumably forms the bulk of the T3S C-ring . Stone et al extended these findings to show that CdsN, the ATPase, is also involved in this complex as well as interacting with the proposed plug protein, CopN .
Flagellar motility is an ancient, conserved mechanism that may have evolved from the same ancestor as T3S . This motility facilitates bacterial migration towards less hostile environments. In non-motile bacteria, however, the presence of flagella would be evolutionarily redundant and energetically expensive, unless the proteins played a role in another mechanism involving bacterial replication or survival. Although C. pneumoniae is thought to be a non-motile bacteria, it has been shown to contain at least three orthologs of flagellar genes, namely flhA, fliF, and fliI [22, 23]. Microarray and proteomic experiments have suggested that these genes are expressed at mid-cycle . The proteins encoded by these genes are paralogs of the T3S proteins CdsV, CdsJ and CdsN, respectively. In motile bacteria, FlhA orthologs are integral membrane proteins required for flagellin export and swarming differentiation which interact with soluble components of the flagellar system [24, 25]. FliF orthologs are integral membrane components that form the membrane and supramembrane (MS) ring . FliF forms a base for the other membrane components to form a molecular pore, through which components of the flagella that exist outside the cell membrane are exported. The flagellar ATPase, FliI orthologs, provide energy for construction of the flagellum by aiding in export of flagellar proteins outside the bacterial cell where the proteins form molecular complexes [27, 28]. The presence of FliI, FlhA and FliF in C. pneumoniae is not sufficient to form a fully functional flagellar apparatus but they could potentially form a rudimentary base for a flagellum structure . In chlamydiae, the identity of other proteins (if they exist) that play important roles in the flagellar apparatus is currently pending, but it is possible that the flagellar apparatus, if it exists, is a hybrid structure of C. pneumoniae T3S and flagellar proteins. Another possibility is that flagellar proteins are involved in T3S, aiding in secretion of effector proteins or structural components. In Pseudomonas, there is evidence to support that flagellar assembly actually antagonizes the T3SS, suggesting a negative cross-regulation of the two systems . No interaction between chlamydial T3S and flagellar components, however, has been reported to our knowledge.
The protein interactions that occur within the bacterial flagellar system have been characterized previously [29, 31, 32]. Genetic evidence, followed by direct biochemical assays, suggests an interaction of FlhA and FliF [33, 34]. The C-terminal end of FlhA, which is predicted to be cytoplasmic, is known to interact with the soluble components of the flagellar system such as FliI, FliH and FliJ [34, 35]. FliH acts as a negative regulator of the flagellar ATPase, FliI, and binds FliI as a homodimer, forming a trimeric (FliI)(FliH)2 complex [36–38]. FliJ, a second soluble component which interacts with FlhA, acts as a general chaperone for the flagellar system to prevent premature aggregation of export substrates in the cytoplasm, and also interacts with the FliH/FliI complex . This complex of FliI/FliH/FliJ is believed to be crucial for selection of export substrates and construction of the flagellar apparatus, although the proton motive force could play a role in the actual secretion of flagellar proteins [28, 40]. In C. pneumoniae, FliH and FliJ have not been annotated in the genome.
FliI, the putative C. pneumoniae flagellar ATPase ortholog, has significant amino acid similarity with both CdsN, the C. pneumoniae T3S ATPase, and FliI, the Salmonella flagellar ATPase, suggesting that it possesses enzymatic activity. Here we report an initial characterization of FliI, the flagellar ATPase, and show that it hydrolyzes ATP at a rate similar to that of its T3S ATPase paralog CdsN as well as orthologs in other bacteria [16, 41, 42]. We have also characterized the protein-interactions occurring between FliI, FliF and FlhA, demonstrating a direct interaction of FliI and FlhA, and FlhA and FliF. As well as interactions between the flagellar proteins, we have also characterized four novel interactions between the flagellar and T3S components. The role of these interactions in the chlamydial replication cycle is discussed.
Sequence analysis of FliI, FlhA and FliF
FlhA (Cpn0363) is 583 amino acids in length with a predicted molecular mass of 65.6 kDa and a pI of 5.60. The FlhA paralog in C. pneumoniae is the T3S protein CdsV. FlhA has seven predicted transmembrane regions in the N-terminal half of the protein (FlhA1-308), while the C-terminal half of the protein is predicted to be cytoplasmic (TMpred). FlhA from C. pneumoniae has 21 percent sequence orthology with FlhA from Salmonella.
FliF (Cpn0860) is 342 amino acids in length with a predicted molecular mass of 38.2 kDa and a pI of 9.5. The FliF paralog in C. pneumoniae is the T3S protein CdsJ. FliF has two predicted TM regions, one located near the N-terminus and one located near the C-terminus. FliF from C. pneumoniae is only 15 percent similar to FliF from Salmonella.
Expression and ATPase activity of FliI
FlhA interacts with FliF
Interaction between the flagellar proteins of C. pneumoniae using the Bacterial-2-hybrid System
β-Galactosidase Activity in units/mg bacteria
pT18 + pT25
412.0 ± 82.4
pT18: Empty vector
pT25: Empty vector
pT18-PknD + pT25-CdsD-FHA-2
996.3 ± 50.0
FliI: Putative flagellar ATPase
FliF: Putative flagellar MS ring protein
pT18-FliI + pT25-FliF
396.4 ± 32.1
FlhA: Putative flagellar integral membrane
pT18-FliF + pT25-Cpn0859
421.1 ± 25.9
pT18-FliI + pT25-Cpn0706
404.4 ± 19.5
Cpn0859: Hypothetical C. pneumoniae
pT18-Cpn0706 + pT25-FlhA
443.0 ± 32.3
Cpn0706: Putative T3S chaperone
pT18-FliF + pT25-FlhA
847.2 ± 21.2
CdsL: Putative T3S ATPase tethering
pT18-FliI + pT25-FlhA
942.9 ± 123.1
pT18-FliI + pT25-CdsL
874.3 ± 59.3
CopN: Putative T3S plug protein
pT18-FliI + pT25-CopN
943.2 ± 74.2
Cpn0322: Putative CdsU ortholog
pT18-Cpn0322 + pT25-FlhA
779.9 ± 32.7
pT18-CdsL + pT25-FlhA
832.1 ± 23.3
FliI interacts with FlhA
In orthologous systems, it has been shown that FlhA interacts with several soluble
components of the flagellar machinery, including the ATPase, FliI . Therefore, we investigated the possibility of whether FlhA interacts with FliI in C. pneumoniae. The bacterial-2-hybrid system was initially used to screen for potential protein interactions. FlhA interacted with FliI, with β-galactosidase activity of 942.9 ± 123.1 units of activity as compared to the negative control with a value of 412.0 ± 82.4 units of activity (Table 1). To confirm these protein-protein interactions we used GST pull-down assays (Figure 3B). Initially FliI was cloned as three constructs, full length FliI, a C-terminal truncation of FliI (FliI1-400) and a N-terminal truncation of FliI (FliI150-471). These three constructs were tested for interaction with the His-FlhA308-583 construct. Full length GST-FliI co-purified with His-FlhA308-583, suggesting that the cytoplasmic fragment of FlhA contains the interactive domain. To determine the region of FliI that interacts with FlhA, we reacted the two truncation constructs of FliI with the cytoplasmic domain of FlhA. Only FliI1-400 was able to co-purify with FlhA, and not FliI150-471, suggesting that the FlhA binding domain resides in the N-terminal 150 amino acids of FliI (Figure 3B). We next wanted to know if FliI interacts with FliF. We therefore reacted GST-FliI against the two FliF constructs and found that there was no co-purification, suggesting that any interaction between FliI and FliF, if there is an association, would seem to be indirect and mediated through the action of FlhA or other intermediate proteins (Figure 3C).
Cpn0859 interacts with FliI and FlhA
FliI and FlhA interact with T3S components
Sequencing of several Chlamydial genomes revealed a conserved set of flagellar orthologs, despite the fact that C. pneumoniae lack a flagellum and are considered non-motile bacteria [22, 23]. Here we report an initial characterization of three annotated flagellar proteins of C. pneumoniae, FliI, FlhA and FliF, demonstrating ATPase activity of FliI and interactions between these flagellar orthologs. We have demonstrated that FliI hydrolyzes ATP in a linear, time-and dose-dependant manner, with optimal activity at a pH of 8.0 and a temperature of 37°C. FliI also interacts with the cytoplasmic domain of FlhA, while FlhA interacts with the C-terminal region of the FliF protein. No direct interaction of FliI and FliF was detected. Also, we have characterized an interaction of both FlhA and FliI with Cpn0859, a fourth unannotated protein. We also show that FliI interacts with CdsL and CopN, two T3S components, while FlhA interacts with CdsL and a third T3S component, CdsU. Collectively, this data suggests that the flagellar proteins of C. pneumoniae interact in a specific way with T3S proteins and may play an important, as yet unidentified role in the chlamydial replication cycle.
FliI hydrolyzes ATP in a linear, time- and dose-dependant manner at a rate of 0.15 ± .02 μmol min-1 mg-1. This rate is typical of other secretion ATPases such as CdsN, EscN, or FliI from other bacterial species [16, 41, 42]. The optimal pH for FliI ATPase activity is 8.0, which is the same as that for other flagellar ATPases . Extreme low or high pH greatly reduced the activity, possibly due to protein denaturation. Also, the enzyme activity peaked at a temperature of 37°C and declined substantially beyond that. Although the formation of higher-order complexes was not explored here, other flagellar ATPases are thought to form a hexameric complex .
The presence of three flagellar genes in chlamydiae is intriguing since chlamydiae are thought to be non-motile and not to possess flagella. FliF, FlhA and FliI alone do not contain all the necessary components for a functional flagella or secretion apparatus, however, a rudimentary basal body or pore complex could be formed by these three components. It is known that the most rudimentary flagellar structure that can be assembled is the MS ring, which consists of only the FliF protein . We have shown that these proteins interact with one another (FliI, FlhA and FliF), most likely at the inner membrane of C. pneumoniae. The interaction between FliI and FlhA is mediated by the N-terminal 150 amino acids of FliI and appears to be specific since it is not disrupted by high salt (500 mM). Only the cytoplasmic domain of FlhA (amino acids 308-583) was utilized in the GST pull-down, suggesting that any protein interactions that occur are within this region. Protein interaction studies with the full length FlhA protein are difficult due to the presence of seven transmembrane domains rendering full length FlhA insoluble and making this portion of the protein unable to bind to soluble flagellar components. Since FlhA is known to interact with soluble components of the flagellar apparatus in other bacteria, it is expected that the cytoplasmic domain mediates an interaction with FliI . FliF is known to form the MS ring in flagellated bacteria, and is one of the first components of the flagellar basal body to be incorporated into the membrane [26, 29]. We detected an interaction of the C-terminal 70 amino acids of FliF with the cytoplasmic domain of FlhA. These interactions were also stable in 500 mM NaCl, suggesting that the interaction is specific. We did not, however, detect any interaction between FliI and FliF, suggesting that any interaction between those two components may be mediated through the action of another protein, possibly FlhA
Bacterial type III secretion (T3S) and flagellar secretion systems are structurally similar, and may have a common ancestry . Although C. pneumoniae does not contain a full repertoire of flagellar genes, it does encode a complete T3S system which most likely consists of specific protein complexes located in the inner membrane [16, 20, 23]. We have characterized an interaction of FliI with CdsL, the T3S ATPase tethering protein. The C. pneumoniae FliH ortholog has not yet been identified, and in the absence of FliH, CdsL may play a regulatory role for both FliI and CdsN. FliI also interacts with the CopN, the T3S plug protein, suggesting that FliI may be involved in either the secretion of effector proteins or regulation of the T3S system. YscU orthologs have a flagellar paralog, FlhB, and Cpn0322 is believed to be the C. pneumoniae YscU ortholog (CdsU). FlhB is known to interact with FlhA, but in C. pneumoniae no FlhB ortholog has been annotated. We found that FlhA interacts with CdsU, suggesting integration of FlhA into the inner membrane, associating with T3S components.
Based on all of our observations, it is possible that the flagellar proteins may interact with components of the T3S injectisome, forming a hybrid structure, thereby playing an ancillary or accessory role in secretion of type III effectors across either the cytoplasmic or inclusion membrane. Another possibility is that there are other, as yet unannotated proteins that play a role in a putative flagellar system in C. pneumoniae. For example, along with the FliH/FliI complex that is formed in other bacteria, another protein, FliJ, which is a general chaperone, is believed to be involved in this complex [39, 44]. FliJ has not been identified in C. pneumoniae. In the absence of a genetic manipulation system for the chlamydiae, direct evidence for the role of these flagellar proteins remains elusive. The fact that FliI is enzymatically active and forms complexes in vitro with other flagellar proteins, all of which are present in all other chlamydiae sps. studied to date, suggests that these proteins play an important role in chlamydial replication or survival. Further studies using heterologous systems and genetic complementation could help to decipher the exact role of these flagellar proteins in chlamydiae.
C. pneumoniae CWL029 (VR1310:ATCC) (GenBank accession # AE001363) was the strain used to isolate genomic DNA for cloning and protein expression. Full length fliI, Cpn0859, cdsL, copN, Cpn0322, and fragments of flhA, fliF, and fliI were amplified from CWL029 using AttB-containing primers (Gateway; Invitrogen). The amplified products were cloned into pDONR201 (Gateway; Invitrogen) to generate pENT vectors. The pENT vectors were then used in LR reactions (Gateway; Invitrogen) to produce pEX vectors containing the genes of interest. We used either pEX17 (N terminal His tag) or pEX15 (N terminal GST tag) vectors for our protein expression. All constructs were confirmed by sequencing at the Molecular Biology Facility at McMaster University.
To identify protein interactions we utilized the bacterial-2-hybrid system . Genes of interest were cloned into either pT18 or pT25 plasmids, each of which expresses a different fragment of adenylate cyclase. When these two plasmids are co-transformed, expressing the protein of interest fused to the adenylate cyclase fragment, any interaction between the two proteins results in production of cAMP. Increases in cAMP results in an increase in the β-galactosidase gene that can be monitored using β-galactosidase activity assays. pT18 and pT25 were digested with KpnI (New England Biolabs) as well as genes amplified from CWL029 (fliI, flhA, fliF, cdsL, Cpn0322, copN) that had a KpnI site designed into the primers. Ligation was performed overnight at 16°C using T4 Ligase (Invitrogen) and the resulting mixture was used to transform E. coli XL-1 cells and transformants were selected on 100 μg/μL ampicillin and 34 μg/μL chloramphenicol (Luria Bertani) LB plates. Plasmids were prepared using the GenElute Plasmid Miniprep Kit (Sigma).
All constructs were expressed in E. coli Rosetta pLysS. Expression plasmids were used to transform E. coli Rosetta pLysS and plated on LB plates containing 100 μg/mL ampicillin. LB broth (750 mL), containing antibiotics, was then inoculated with 12 mL of an overnight culture and grown at 37°C until they reached an optical density (OD)600 of approximately 0.8. Cultures were then cooled on ice to 20°C and induced with 0.2 mM of isopropyl β-D galactosidase (IPTG). Cultures were then incubated at 23°C for 2 hours and bacteria were harvested by centrifugation at 6500 × g for 10 minutes in a Sorvall RC-5B centrifuge and washed with ice-cold phosphate buffered saline (PBS). Bacteria containing His-tagged protein were resuspended in Binding Buffer (50 mM potassium phosphate pH 7.2, 150 mM KCl, 1 mM MgCl2) while the bacteria containing GST-tagged protein were resuspended in PBS and stored at -20°C until further use.
Purification of Recombinant Proteins
E. coli pellets containing over-expressed proteins were thawed on ice and sonicated using a Fischer Scientific Sonic Dismembrator Model 100, followed by centrifugation at 20,000 × g for 40 minutes to remove insoluble material. Supernatants containing His-tagged protein were stored at 4°C for use in GST pull-down assays while the GST-tagged protein supernatents were filtered through 0.45 μm acrodisc filters (Pall Corporation) and incubated overnight at 4°C with 300 μL of Glutathione-agarose beads (Sigma). For GST pull-down assays, beads were blocked overnight in Tris Buffered Saline with 0.1% Tween-20 and 4% BSA and stored at 4°C until use. For ATPase activity measurements, glutathione beads were washed on a column with PBS + 0.1% Tween until the flow-through had an OD280 of less than 0.005. GST-tagged protein was then eluted off the beads using 1.5 μg/μL reduced glutathione (Sigma) and dialyzed against activity buffer (50 mM Tris-HCL pH 7.0, 5 mM MgCl2, 10 mM KCl). Purity was confirmed using SDS-PAGE and Coomassie blue staining.
In order to determine whether Cpn0859 formed dimers, formaldehyde fixation and non-denaturing PAGE were used. His-Cpn0859 was purified from Ni-NTA beads, dialyzed against PBS and concentrated using Amicon 10 kDa (Millipore) concentrators to a final concentration of 1 μg/μl. Formaldehyde was added to purified His-Cpn0859 to a final concentration of 10% and fixation was allowed to continue for 10 minutes. Samples containing 1 μg of Cpn0859 were electrophoresed on an 8% non-denaturing PAGE and visualized by Western blot using anti-His antibody (Sigma).
ATP hydrolysis by GST-FliI purified from glutathione-agarose beads was measured using a malachite green assay (R & D Systems). For all experiments, the specific activity was determined using the equation of a standard line generated using phosphate standard (R & D Systems). Reaction mixtures contained 150 ng of GST-FliI, 4 mM ATP, 50 mM Tris-HCL pH 7.0, 5 mM MgCl2, and 10 mM KCl. The reaction mixture (1 mL) was incubated at 37°C for 1 hour and 50 μL of the mixture was taken for inorganic phosphate determination at various time points. The reaction was stopped by the addition of 10 μL of Malachite Green Reagent A followed by 10 μL of Malachite Green Reagent B and incubated at room temperature for one minute before an OD610 reading was taken, according to the manufacturer's instructions. For the negative control, purified FliI was digested for 10 minutes at 37°C using Proteinase K (Invitrogen). Also, as a negative control, another GST-tagged protein (CopN) known not to have ATPase activity was purified in the same manner and tested for activity. ATPase activity was expressed as μmol phosphate released min-1 mg-1 of protein, and all experiments were performed in triplicate.
GST Pull-down Assays
To examine the interaction of the flagellar proteins, GST pull-down assays were performed as described previously with the following modifications . Briefly, glutathione agarose beads (30 μL) bound to fifty nanograms of GST tagged FliI, Cpn0859, or FlhA was used in the assay. The beads were incubated overnight at 4°C with the E. coli lysate expressing the His-tagged proteins. The beads were collected by centrifugation and washed with increasing concentrations of NaCl to eliminate spurious protein interactions. All proteins were eluted from the Glutathione beads and electrophoresed on an 11% SDS-PAGE gel before being probed for His-tagged protein. As a negative control, GST alone was incubated on beads with the E. coli lysates.
The bacterial-2-hybrid assay uses protein-protein interactions to bring two fragments of adenylate cyclase catalytic domain together to produce cAMP, stimulating β-galactosidase activity. β-galactosidase activity is therefore a representation of protein interaction. This protocol was performed as described by Karimova et al, 2005 . Briefly, E. coli DHP-1 cells (an adenylate cyclase deficient cell line) were transformed using pT18-FliI/pT18-FlhA/pT18-FliF and either pT25-FlhA or pT25-FliF and selected with 100 μg/μL ampicillin and 34 μg/μL chloramphenicol. Three individual colonies were selected from each plate and grown overnight in 3.0 mL of LB at 30°C in the presence of 0.5 mM IPTG plus appropriate antibiotics. Overnight culture (200 μL) was diluted 1 in 5 into M63 buffer (75 mM (NH4)2SO4, 110 mM KH2PO4, 200 mM K2HPO4, 5 mM FeSO4-7H2O) and the optical density at 600 nm was recorded. The cells were permeabilized using 0.01% Toluene and 0.01% SDS. For the reaction, 50 μL of the permeabilized cells were diluted into 450 μL of LB broth. The diluted cells were then added to 500 μL of PM2 (70 mM Na2HPO4-H2O, 30 mM NaHPO4-H2O, 1 mM MgSO4, and 0.2 mM MnSO4) buffer containing 100 mM β-mercaptoethanol. The reaction was initiated by adding 250 μL of 12 mg/mL ortho-nitrophenyl-β-galactoside and allowed to continue for 15 seconds at 28°C. The reaction was stopped by the addition of 500 μL of 1.0 M Na2CO3. The absorbance was measured at 420 nm and the β-galactosidase activity was expressed as units of β-galactosidase activity per milligram of bacteria. Empty pT18 and pT25 vectors were transformed into E. coli DHP1 cells as a negative control and pT18-CopN and pT25-CdsN were used as a positive control (38). The cutoff for a positive interaction (677 units activity/mg bacteria) was determined as the mean plus two standard deviations of the negative control values obtained from 20 assays.
We would like to thank Dr. Patrik Bavoil for scientific discussion involving the flagellar proteins. CBS is a recipient of a Father Sean O'Sullivan Research Center Studentship. This research was funded in part by a Canadian Institute of Health Research grant to JBM.
- Hahn D, Azenabor A, Beatty W, Byrne G: Chlamydia pneumoniae as a respiratory pathogen. Front Biosci. 2002, 7: e66-e76. 10.2741/hahn.View ArticlePubMedGoogle Scholar
- Grayston J: Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis. 2000, 181: S402-S410. 10.1086/315596.View ArticlePubMedGoogle Scholar
- Ardeniz O, Gulbahar O, Mete N, Cicek C, Basoglu OK, Sin A: Chlamydia pneumoniae arthritis in a patient with common variable immunodeficiency. Ann Allergy Asthma Immunol. 2005, 94: 504-508.View ArticlePubMedGoogle Scholar
- Balin B, Little C, Hammond C, Appelt D, Whittum-Hudson J, Gerard H: Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis. 2008, 13: 371-380.PubMedGoogle Scholar
- Clifton D, Fields K, Grieshaber S, Dooley C, Fischer E, Mead D, Carabeo R, Hackstadt T: A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci USA. 2004, 101: 10166-10171. 10.1073/pnas.0402829101.PubMed CentralView ArticlePubMedGoogle Scholar
- Lane B, Mutchler C, Khodor S, Grieshaber S, Carabeo R: Chlamydial entry involves TARP binding of guanine nucleotide exchange factors. PLoS Pathog. 2008, 4: 1-11. 10.1371/journal.ppat.1000014.View ArticleGoogle Scholar
- Coombes B, Mahony J: Identification of MEK- and phosphoinositide-3-kinase-dependant signaling as essential events during Chlamydia pneumoniae invasion of HEp2 cells. Cell Microbiol. 2002, 4: 447-460. 10.1046/j.1462-5822.2002.00203.x.View ArticlePubMedGoogle Scholar
- Moulder J: Interaction of chlamydiae and host cells in vitro. Microbiol Rev. 1991, 55: 143-190.PubMed CentralPubMedGoogle Scholar
- Hatch T: Utilization of L-cell nucleoside triphosphates by Chlamydia psittaci for ribonucleic acid synthesis. J Bacteriol. 1975, 122: 393-400.PubMed CentralPubMedGoogle Scholar
- Moore E, Fischer E, Mead D, Hackstadt T: The Chlamydial inclusion preferentially intercepts basolaterally directed sphingomyelin-containing exocytic vacuoles. Traffic. 2008, 9: 2130-2140. 10.1111/j.1600-0854.2008.00828.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Wylie J, Hatch G, McClarty G: Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bacteriol. 1997, 179: 7233-7242.PubMed CentralPubMedGoogle Scholar
- Heuer D, Lipinski A, Machuy N, Karlas A, Wehrens A, Siedler F, Brinkmann V, Meyer T: Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature. 2009, 457: 731-735. 10.1038/nature07578.View ArticlePubMedGoogle Scholar
- Hoare A, Timms P, Bavoil P, Wilson D: Spatial constraints within the chlamydial host cell inclusion predict interrupted development and persistence. BMC Microbiol. 2008, 8: 5-10.1186/1471-2180-8-5.PubMed CentralView ArticlePubMedGoogle Scholar
- Scidmore M, Hackstadt T: Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol. 2001, 39: 1638-1650. 10.1046/j.1365-2958.2001.02355.x.View ArticlePubMedGoogle Scholar
- Hybiske K, Stephens R: Mechanisms of host cell exit by the intracellular bacterium Chlamydia. Proc Natl Acad Sci USA. 2007, 104: 11430-11435. 10.1073/pnas.0703218104.PubMed CentralView ArticlePubMedGoogle Scholar
- Stone C, Johnson D, Bulir D, Mahony J: Characterization of the putative type III secretion ATPase CdsN (Cpn0707) of Chlamydophila pneumoniae. J Bacteriol. 2008, 190: 6580-6588. 10.1128/JB.00761-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Blaylock B, Riordan K, Missiakas D, Schneewind O: Characterization of the Yersinia enterocolitica type III secretion ATPase YscN and its regulator, YscL. J. Bacteriol. 2006, 188: 3525-3534. 10.1128/JB.188.10.3525-3534.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Fields K, Hackstadt T: Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol. Microbiol. 2000, 38: 1048-1060. 10.1046/j.1365-2958.2000.02212.x.View ArticlePubMedGoogle Scholar
- Riordan K, Schneewind O: YscU cleavage and the assembly of Yersinia type III secretion machine complexes. Mol Microbiol. 2008, 68: 1485-1501. 10.1111/j.1365-2958.2008.06247.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Johnson D, Stone C, Mahony J: Interactions between CdsD, CdsQ, and CdsL, three putative Chlamydophila pneumoniae type III secretion proteins. J Bacteriol. 2008, 190: 2972-2980. 10.1128/JB.01997-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Aizawa S: Bacterial flagella and type III secretion systems. FEMS Microbiol Lett. 2001, 202: 157-164. 10.1111/j.1574-6968.2001.tb10797.x.View ArticlePubMedGoogle Scholar
- Kalman S, Michell W, Marathe R, Lammel C, Fan J, Hyman R, Olinger L, Grimwood J, Davis R, Stephens R: Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet. 1999, 21: 385-389. 10.1038/7716.View ArticlePubMedGoogle Scholar
- Peters J, Wilson J, Myers G, Timms P, Bavoil P: Type III secretion a la Chlamydia. Trends Microbiol. 2007, 15: 241-251. 10.1016/j.tim.2007.04.005.View ArticlePubMedGoogle Scholar
- Ghelardi E, Celandroni F, Salvetti S, Beecher D, Gominet M, Lereclus D, Wong A, Senesi S: Requirement of flhA for swarming differentiation, flagellin export, and secretion of virulence-associated proteins in Bacillus thuringiensis. J Bacteriol. 2002, 184: 6424-6433. 10.1128/JB.184.23.6424-6433.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- McMurry J, Arnam J, Kihara M, Macnab R: Analysis of the cytoplasmic domains of Salmonella FlhA and interactions with components of the flagellar export machinery. J Bacteriol. 2004, 186: 7586-7592. 10.1128/JB.186.22.7586-7592.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Bigot A, Pagniez H, Botton E, Frehel C, Dubail I, Jacquet C, Charbit A, Raynaud C: Role of FliF and FliI of Listeria monocytogenes in flagellar assembly and pathogenicity. Infect Immune. 2005, 73: 5530-5539. 10.1128/IAI.73.9.5530-5539.2005.View ArticleGoogle Scholar
- Akeda Y, Galan J: Chaperone release and unfolding of substrates in type III secretion. Nature. 2005, 437: 911-915. 10.1038/nature03992.View ArticlePubMedGoogle Scholar
- Paul K, Erhardt M, Hirano T, Blair D, Hughes K: Energy source of flagellar type III secretion. Nature. 2008, 451: 489-492. 10.1038/nature06497.View ArticlePubMedGoogle Scholar
- Kubori T, Shimamoto N, Yamaguchi A, Namba K, Aizawa S: Morphological pathway of flagellar assembly in Salmonella typhimurium. J Mol Biol. 1992, 226: 433-446. 10.1016/0022-2836(92)90958-M.View ArticlePubMedGoogle Scholar
- Soscia C, Hachani A, Bernadac A, Filloux A, Bleves S: Cross talk between type III secretion and flagellar assembly systems in Pseudomonas aeruoginosa. J Bacteriol. 2007, 189: 3124-3132. 10.1128/JB.01677-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Berg H: The rotary motor of bacterial flagella. Annu Rev Biochem. 2003, 72: 19-54. 10.1146/annurev.biochem.72.121801.161737.View ArticlePubMedGoogle Scholar
- Marykwas D, Schmidt S, Berg H: Interacting components of the Flagellar Motor of Escherichia coli revealed by the two-hybrid system in Yeast. J Mol Bio. 1996, 256: 564-576. 10.1006/jmbi.1996.0109.View ArticleGoogle Scholar
- Kihara M, Minamino T, Yamaguchi S, Macnab R: Intergenic suppression between the flagellar MS ring protein FliF of Salmonella and FlhA a membrane component of its export apparatus. J Bacteriol. 2001, 183: 1655-1662. 10.1128/JB.183.5.1655-1662.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- McMurry J, Arnam J, Kihara M, Macnab R: Analysis of the cytoplasmic domains of Salmonella FlhA and interactions with components of the flagellar export machinery. J Bacteriol. 2004, 186: 7586-7592. 10.1128/JB.186.22.7586-7592.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Minamino T, Macnab R: Interactions among components of the Salmonella flagellar export apparatus and its substrates. Molecular Microbiology. 2000, 35: 1052-1064. 10.1046/j.1365-2958.2000.01771.x.View ArticlePubMedGoogle Scholar
- Minamino T, Macnab M: FliH a soluble component of the type III flagellar export apparatus of Salmonella, forms a complex with FliI and inhibits ATPase activity. Mol Microbiol. 2000, 37: 1494-1503. 10.1046/j.1365-2958.2000.02106.x.View ArticlePubMedGoogle Scholar
- Okabe M, Minamino T, Imada K, Namba K, Kihara M: Role of the N-terminal domain of FliI ATPase in bacterial flagellar protein export. FEBS lett. 2009, 583: 743-748. 10.1016/j.febslet.2009.01.026.View ArticlePubMedGoogle Scholar
- Pallen M, Bailey C, Beatson S: Evolutionary links between FliH/YscL-like proteins from bacterial type III secretion systems and second-stalk components of the F0F1 and vacuolar ATPases. Protein Sci. 2006, 15: 935-940. 10.1110/ps.051958806.PubMed CentralView ArticlePubMedGoogle Scholar
- Fraser G, Gonzalez-Pedrajo B, Tame J, Macnab R: Interactions of FliJ with the Salmonella type III flagellar export apparatus. J Bacteriol. 2003, 185: 5546-5554. 10.1128/JB.185.18.5546-5554.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Minamino T, Namba K: Distinct roles of the FliI ATPase and proton motive force in bacterial flagellar protein export. Nature. 2008, 451: 485-488. 10.1038/nature06449.View ArticlePubMedGoogle Scholar
- Andrade A, Pardo J, Espinosa N, Perez-Hernandez G, Gonzalez-Pedrajo B: Enzymatic characterization of the enteropathogenic Escherichia coli type III Secretion ATPase EscN. Arch Biochem Biophys. 2007, 468: 121-127. 10.1016/j.abb.2007.09.020.View ArticlePubMedGoogle Scholar
- Fan F, Macnab R: Enzymatic characterization of FliI. J Biol Chem. 1996, 271: 31981-31988. 10.1074/jbc.271.44.27237.View ArticlePubMedGoogle Scholar
- Imada K, Minamino T, Tahara A, Namba K: Structural similarity between the flagellar type III ATPase FliI and F1-ATPase subunits. Proc Natl Acad Sci USA. 2007, 104: 485-490. 10.1073/pnas.0608090104.PubMed CentralView ArticlePubMedGoogle Scholar
- Minamino T, Chu R, Yamaguchi S, Macnab R: Role of FliJ in flagellar protein export in Salmonella. J. Bacteriol. 2000, 182: 4207-4215. 10.1128/JB.182.15.4207-4215.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Karimova G, Dautin N, Ladant D: Interaction network among Escherichia coli membrane proteins involved in cell division as revealed by bacterial two-hybrid analysis. J Bacteriol. 2005, 187: 2233-2243. 10.1128/JB.187.7.2233-2243.2005.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.